Circumvent Pharmaceuticals, Inc. — Form C (Regulation Crowdfunding)
Circumvent Pharmaceuticals, Inc. of Portland, OR filed a Form C (Regulation Crowdfunding) with the SEC on 2021-07-12. Target raise $25K, up to $250K. Offered through Bioverge Portal.
Offering
- Filed: 2021-07-12
- Form: C
- Accession: 0001213900-21-036400
- Target amount: $25K
- Maximum amount: $250K
- Security type: Other
- Securities offered: 25,000
- Price: $25000.0000
- Deadline: 2021-12-31
- Funding portal / intermediary: Bioverge Portal
- Intermediary file number: 007-00157
- Intermediary CRD: 005022636
Issuer
- CIK: 0001855639
- Website: www.circumventpharmaceuticals.com
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2015-08-24
- Address: 4640 SW Macadam Ave., Suite 200, Portland, OR, 87239
- Employees: 4
Financials (as filed)
- Total assets (most recent): $1.7M
- Cash (most recent): $1.7M
- Revenue (most recent): $1K
- Revenue (prior): $906
- Net income (most recent): $-888K
- Net income (prior): $-630K
- Short-term debt: $56K
- Long-term debt: $3.3M
People (4)
| Name | Role | Location |
|---|
| Andrew Lim | Chief Executive Officer | Portland, OR |
| Andrew Lim | Director, Chief Executive Officer, and Principal Financial Officer | Portland, OR |
| Samy Hamdouche | Director and Chief Business Officer | Portland, OR |
| Devin Wiley | Director and Chief Medical Officer | Portland, OR |
More